Compare TMO & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMO | MS |
|---|---|---|
| Founded | 1956 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.4B | 278.0B |
| IPO Year | N/A | N/A |
| Metric | TMO | MS |
|---|---|---|
| Price | $570.86 | $177.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 14 |
| Target Price | ★ $630.42 | $170.42 |
| AVG Volume (30 Days) | 1.6M | ★ 5.7M |
| Earning Date | 01-29-2026 | 01-15-2026 |
| Dividend Yield | 0.30% | ★ 2.24% |
| EPS Growth | 8.54 | ★ 48.48 |
| EPS | ★ 17.32 | 9.75 |
| Revenue | $43,736,000,000.00 | ★ $68,532,000,000.00 |
| Revenue This Year | $4.33 | $17.60 |
| Revenue Next Year | $4.94 | $5.64 |
| P/E Ratio | $33.05 | ★ $18.30 |
| Revenue Growth | 3.22 | ★ 17.59 |
| 52 Week Low | $385.46 | $94.33 |
| 52 Week High | $610.97 | $181.98 |
| Indicator | TMO | MS |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 68.41 |
| Support Level | $561.91 | $168.10 |
| Resistance Level | $579.08 | $181.98 |
| Average True Range (ATR) | 10.97 | 3.36 |
| MACD | -2.81 | 1.04 |
| Stochastic Oscillator | 26.08 | 84.62 |
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.